Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results


The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.

https://www.cnbc.com/2024/09/14/pfizers-cancer-cachexia-drug-shows-positive-midstage-trial-results.html